BVS.US Bioventus Inc

Healthcare Health Care Equipment & Supplies USA Stocks
10.66 USD
Close of Nov 14, 2026
6.47 15.89
Market cap
USD 730M
P/E
13.2x
P/B
3.09x
ROE
23.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BVS.US undervalued?

Graham number
Price10.66
Graham value7.93
Premium34.5%

BVS.US trades 34.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bioventus Inc fundamental analysis

No fundamental analysis for Bioventus Inc yet.

Bioventus Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bioventus Inc

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimul…

Full company profile